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Abstract
The main challenge in addressing the role of DNA methylation in human behaviour is the fact that the brain is inaccessible
to epigenetic analysis in living humans. Using positron emission tomography (PET) measures of brain serotonin (5-HT)
synthesis, we found in a longitudinal sample that adult males with high childhood-limited aggression (C-LHPA) had lower
in vivo 5-HT synthesis in the orbitofrontal cortex (OBFC). Here we hypothesized that 5-HT alterations associated with
childhood aggression were linked to differential DNA methylation of critical genes in the 5-HT pathway and these changes
were also detectable in peripheral white blood cells. Using pyrosequencing, we determined the state of DNA methylation of
SLC6A4 promoter in T cells and monocytes isolated from blood of cohort members (N=25) who underwent a PET scan, and
we examined whether methylation status in the blood is associated with in vivo brain 5-HT synthesis. Higher levels of
methylation were observed in both T cells and monocytes at specific CpG sites in the C-LHPA group. DNA methylation of
SLC6A4 in monocytes appears to be associated more reliably with group membership than T cells. In both cell types the
methylation state of these CpGs was associated with lower in vivo measures of brain 5-HT synthesis in the left and right
lateral OBFC (N=20) where lower 5-HT synthesis in C-LHPA group was observed. Furthermore, in vitro methylation of the
SLC6A4 promoter in a luciferase reporter construct suppresses its transcriptional activity supporting a functional role of DNA
methylation in SLC6A4 promoter regulation. These findings indicate that state of SLC6A4 promoter methylation is altered in
peripheral white blood cells of individuals with physical aggression during childhood. This supports the relevance of
peripheral DNA methylation for brain function and suggests that peripheral SLC6A4 DNA methylation could be a marker of
central 5-HT function.
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Introduction
It is important to study the interactions between epigenetic
processes such as DNA methylation and human behaviours. This
is a challenging task if we wish to establish a link between the
behaviours in living human subjects and their epigenetic profile, as
brain samples cannot be readily obtained for analysis. Therefore,
alternative methods of epigenetic analysis must be identified. A
logical approach will be to understand the relationship between
expression of critical neurotransmitter systems in the brain and
DNA methylation in cells of the relatively easily accessible
peripheral system. Given the role of serotonin (5-HT) in a wide
range of psychopathologies including impulsive aggression and
recently reported associations between DNA methylation in 5-HT
genes and depressive symptoms [1,2], investigation of associations
between DNA methylation in 5-HT genes and brain 5-HT
function is of particular interest.
Observations in humans and animals have shown that
aggressive behaviour is associated with low 5-HT neurotransmis-
sion [3,4]. Using positron emission tomography (PET), we
previously compared, in a longitudinal sample followed since
childhood, in vivo brain 5-HT synthesis in healthy adult males with
high and low levels of childhood physical aggression [5]. We found
that adult males with high childhood-limited aggression (C-LHPA)
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cortex (OBFC) relative to individuals with low aggression in
childhood (LPA), even though there were no group differences in
current behaviours or psychosocial functioning [5]. In the present
study, we tested whether DNA methylation changes are involved
in the long-term reduction of in vivo measures of 5-HT synthesis
and associated childhood-limited aggressive behaviours. This was
based on our previous DNA methylation studies showing that
early life experiences result in stable changes in DNA methylation
that affect long-term gene expression programming and the
phenotype [6,7,8], and the hypothesis that the DNA methylation
response to early life adversity is not necessarily limited to the
brain [9].
Serotonin transporter (SLC6A4/5HTT) was selected as a
candidate gene, given its crucial and widely demonstrated role
in brain development [10,11] and aggression [12,13]. Also,
preliminary data generated by genomic methylated DNA immu-
noprecipitation microarray (MeDIP-chip) using isolated T cells
from the blood of the same cohort, indicated altered methylation
at the SLC6A4 gene promoter upstream of the transcription start
site (TSS) in chronically aggressive individuals (Provenc ¸al,
unpublished observations). Since DNA methylation patterns are
cell-type selective [14], we isolated white blood cell types (T cells
and monocytes) using immunomagnetic separation to reduce the
complexity of the DNA methylation patterns. We quantified the
state of DNA methylation of SLC6A4 in T cells and monocytes
isolated from blood of healthy males that were followed
prospectively since childhood using pyrosequencing. The DNA
methylation results were correlated with PET data from the same
individuals to examine whether the state of DNA methylation in
peripheral T cells and monocytes is associated with childhood-
limited aggression and in vivo measures of brain 5-HT synthesis.
We also explored the association between the widely investigated
SLC6A4 genotype (ss, sl, ll; [15]) and DNA methylation in the
SLC6A4 gene. Finally, to test whether DNA methylation plays a
functional role in SLC6A4 gene transcription, we subcloned a
fragment of the SLC6A4 promoter into a CpG-free pCpGL-basic
luciferase reporter plasmid, in vitro methylated the promoter CpGs
and measured luciferase activity in JAR cells that express SLC6A4
endogenously.
Results
SLC6A4 Methylation and Childhood-limited Aggression
DNA methylation status of a 412 bp region upstream of the
SLC6A4 promoter containing 24 CpG sites was quantified using
pyrosequencing in 25 individuals: 18 LPA and 7 C-LHPA
(Figure 1a). This region is enriched with Sp1 binding sites, as
well as other transcription factors such as ER, GR, Krox-20,
RXR-beta and RAP1 (Figure 1a) as determined using TRANS-
FAC database (Alibaba 2.1).
T Cells. The mean percentage in DNA methylation across all
the 24 CpG sites (6SE) for T cells was 5.3160.5%. Differences in
average methylation levels across all CpG sites between the C-
LHPA and LPA group were not significant (4.3160.5% and
5.7760.7%, respectively, p=0.25). A more detailed examination
of DNA methylation levels at the level of the individual CpG sites
showed high variability in percentage of methylation across the 24
sites, varying from 1.1660.34% (CpG 20) to 15.8863.91% (CpG
5). Group differences in percentage of methylation were observed
at CpG sites 11 and 12 (Figure 1b). These CpG sites correlated
highly with each other (r=0.53, p=0.008). Examining CpG site
11 and 12 conjointly in a multivariate general linear model
(GLM), allowing to examine and correct for intercorrelations of
CpG sites, showed a multivariate difference between the C-LHPA
group and the LPA group (F(2,21)=4.58, p=0.02, partial
g
2=0.30)). The C-LHPA group had higher levels of SLC6A4
methylation at CpG 11 (F(1,21)=7.01, p=0.01, partial g
2=0.24)
and at CpG12 (F(1,21)=6.35, p=0.02, partial g
2=0.22) com-
pared to the LPA group. When the average methylation levels in
CpG sites 11 and 12 were combined, GLM showed that the group
difference in average methylation levels across CpG site 11 and 12
was also significant (F(1,21)=9.59, p=0.005, partial g
2=0.30).
Monocytes. The average percentage in DNA methylation
across all the 24 CpG sites (6SE) for monocytes was 2.8460.26%,
with a higher percentage in overall methylation across the 24 CpG
sites for the C-LHA group than for the LPA group (3.6160.6%
and 2.4960.2%, F(1,21)=4.47, p=0.047, partial g
2=0.18). As
observed for T cells, there was considerable variability between
CpG sites, varying from 0.7760.08% (CpG 23) to 9.0160.4%
(CpG 15) (Figure 1b). Group differences in percentage of
methylation were observed at CpG sites 5 and 6 (Figure 1b).
These CpG sites correlated considerably with each other (r=0.68,
p,0.001). A multivariate analysis in which these CpG sites were
examined conjointly showed a trend for the overall multivariate
effect (F(2,20)=2.61, p=0.098, partial g
2=0.21). Percentage of
methylation was higher in the C-LHPA group than in the LPA
group for CpG 5 (F(1,21)=4.95, p=0.04, partial g
2=0.19) and
tended to be higher for CpG 6 (F(1,21)=3.79, p=0.06, partial
g
2=0.15). When the average methylation levels in CpG sites 5
and 6 were combined, the group difference in average methylation
levels across CpG site 5 and 6 was significant (F(1,21)=5.48,
p=0.03, partial g
2=0.21). There were no group differences in the
other investigated CpG sites.
Correlation of SLC6A4 Methylation and In Vivo Brain 5-HT
Synthesis
We then examined whether the rate of 5-HT synthesis as
determined by PET correlates with the state of SLC6A4
methylation in T cells and monocytes. We focused on brain
regions that have previously been associated with childhood-
limited physical aggression [5], and on those CpG sites that were
associated with childhood-limited aggression. Significant associa-
tions were found with the mean methylation of the CpG sites in
SLC6A4 promoter that were affected by aggression, CpG 11 and
12 for T cells (n=20) and CpG 5 and 6 for monocytes (n=19)
respectively (Figure 2). Specifically, negative associations were
observed between the mean methylation of CpG sites 11 and 12 in
T cells and 5-HT synthesis in the lateral left (r=20.67, p=0.001)
and right (r=20.47, p=0.04) OBFC of the brain. The first
correlation remained significant after correction for multiple
comparisons, while the second did not (q=0.02 and q=0.16,
respectively). Significant correlations were found in CpG site 5 and
6 of monocytes as well, where higher mean methylation was
associated with lower 5-HT synthesis in the lateral left (r=20.67,
p=0.002) and right (r=20.65, p=0.003) OBFC regions. These
correlations survived correction for multiple testing (q=0.02 for
both regions). No other voxels of interest (VOI) were associated
with the SLC6A4 methylation data, except that there was a trend of
an association between increased DNA methylation in CpG sites 5
and 6 in monocytes and higher levels of brain 5-HT synthesis in
the left hippocampus (r=0.45, p=0.056), although this association
did not survive correction for multiple comparisons (q=0.18).
Nevertheless, the finding is consistent with a comparable trend
observed between childhood-limited physical aggression and
increased 5-HT synthesis in parts of the hippocampal areas
observed in our previous study [5].
SLC6A4 DNA Methylation and Aggression
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A polymorphic region located in the promoter of SLC6A4 (5-
HTTLPR) is known to affect gene expression, where the long l
allele results in higher SLC6A4 transcription than the shorter s
variant [15,16]. We had genetic information for several subjects
(ss, n=9; sl, n=7; ll, n=4), and found no relationships between
mean methylation levels and 5-HTTLPR genotype, neither in T
cells nor monocytes (p.0.10).
Figure 1. DNA Methylation of the SLC6A4 promoter. (A) Schematic showing region of the SLC6A4 promoter analyzed using sodium bisulfite
pyrosequencing. The transcription start site (TSS) is indicated by the arrow. Positions of the 24 CpG dinucleotides are indicated as solid circles.
Transcription factor binding sites predicted using Alibaba 2.1 are indicated as boxes below the CpG sites. (B) Upper panel represents mean6SEM
percentage of DNA methylation of the C-LHPA (n=8) vs. LPA (n=17) in T cells. Lower panel represents DNA methylation percentage of the C-LHPA
(n=7) vs. LPA (n=16) in monocytes. *p,0.05,
ap=0.06.
doi:10.1371/journal.pone.0039501.g001
SLC6A4 DNA Methylation and Aggression
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Lastly, we generated a 648 bp CpG-free luciferase reporter
plasmid and performed in vitro methylation with SssI DNA
methyltransferase to determine whether SLC6A4 promoter meth-
ylation can affect its transcriptional activity (Figure 3a). DNA
methylation significantly decreased the normalized luciferase
activity (p=0.008), suggesting that methylation of the CpG sites
could potentially play a role in silencing the transcriptional activity
of this promoter region (Figure 3b). We also examined the mRNA
expression of SLC6A4 in T cells using reverse transcription
polymerase chain reaction (RT-PCR). However, levels of mRNA
were very variable between individuals and therefore no significant
differences of SLC6A4 expressions were observed between the high
and low aggression trajectories (n=13).
Discussion
The main challenge in addressing the role of DNA methylation
in human behaviour is the fact that the brain is inaccessible to
epigenetic analysis in living humans. DNA methylation patterns
are, to a large extent, tissue specific [14]. Therefore, it is
anticipated that only a fraction of DNA methylation events will
show correspondence between the periphery and the brain. The
present study has tested, for the first time, correlation of peripheral
white blood cell DNA methylation states and brain imaging of 5-
HT synthesis in healthy adult males with different levels of
childhood physical aggression. These individuals were previously
shown by us to express lower levels of 5-HT in the brain. This
suggests a long-term effect on gene expression in the brain of the
events that were associated with aggression during childhood. We
therefore took advantage of this study to determine whether
changes in brain 5-HT synthesis were associated with changes in
DNA methylation in T cells and monocytes. We found signifi-
cantly higher SLC6A4 promoter DNA methylation in specific CpG
sites in T cells and monocytes isolated from the C-LHPA group
compared with the LPA group. In monocytes, in addition to
increased methylation at specific CpG sites, we observed an
increase in the average DNA methylation across the CpG sites in
the pyrosequenced region. Notably, the T cell DNA methylation
state is less reliably associated with group membership (aggression)
than the monocyte methylation patterns that show overall
multivariate associations with group. There is an ongoing debate
on what is the best source for peripheral information on DNA
methylation for behaviour and brain studies [17]. Our study
provides a preliminary indication for using monocytes as a more
reliable source. However further studies comparing different
Figure 2. Correlations between peripheral methylation and brain 5-HT synthesis. In the upper panel, mean percentage of CpG site 11 and
12 methylation in T cells (n=20) was negatively associated with the in vivo index of 5-HT synthesis (normalized K* value) in the lateral left (r=20.67,
p=0.001) and right OBFC (r=20.47, p=0.04). FDA was used to adjust for multiple testing (q=0.02 and q=0.16, respectively). Bottom panel shows
similar associations of percentage of methylation of CpG site 5 and 6 in monocytes (n=19) vs. lateral left (r=20.67, p=0.002) and right OBFC
(r=20.65, p=0.003). For both regions, q=0.02.
doi:10.1371/journal.pone.0039501.g002
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address this issue.
Higher mean methylation of particular CpG sites was associated
with lower in vivo measures of 5-HT synthesis in the left and right
lateral OBFC, demonstrating an association between peripheral
white blood cell DNA methylation and brain 5-HT synthesis. The
association between SLC6A4 and 5-HT synthesis is supported by
other studies. Previous studies have shown that 5-HT depletion
results in reduced SLC6A4 expression [18]. SLC6A4 knockout mice
have altered brain 5-HT synthesis and concentration, suggesting
that SLC6A4 plays a role in brain 5-HT function [19].
Interestingly, the differentially methylated CpG 6, 11, and 12
were also found to be differentially methylated in another study
that focused on maternal depression [1]. Although we were able to
correlate SLC6A4 methylation with 5-HT synthesis in the brain,
we did not observe differences in SLC6A4 expression in blood cells.
We did not find SLC6A4 genotype and mRNA to be associated
with aggression and mean methylation. Due to small sample size,
it was not possible to test for interaction between genotype and
methylation status on mRNA levels. Therefore, it is uncertain
whether the differential DNA methylation that we observed is
independent of genetic variation. The variability in the mRNA
levels may be caused by low extraction yield of intact RNA due to
sensitivity to processing time [20]. In contrast, DNA is more robust
and methylation remains more constant over time, thus supporting
the conclusion that DNA methylation in peripheral cells is a more
reliable measure of central 5-HT synthesis [21].
Higher levels of SLC6A4 methylation at specific sites in T cells
and monocytes were specifically associated with lower in vivo brain
5-HT synthesis in the lateral left and right OBFC. This is of
particular interest because these specific brain regions also
demonstrated lower 5-HT synthesis in the C-LHPA trajectory
[5]. DNA methylation differences in SLC6A4 gene cannot directly
explain 5-HT synthesis in the brain and other mechanism must be
mediating between changes in SLC6A4 programming and 5-HT
synthesis. Nevertheless, SLC6A4 methylation from blood derived
cells was previously associated with psychiatric disorders such as
depression and alcoholism in humans [1,2]. Furthermore, SLC6A4
has been used as a peripheral marker for various neuropsychiatric
disorders that involve 5-HT alterations [22,23,24].
The luciferase reporter construct has demonstrated a functional
role of DNA methylation on SLC6A4 gene expression. Variable
levels of methylation across the SLC6A4 promoter are observed in
vivo. In vitro methylation of the SLC6A4 promoter including the
CpG sites associated with aggressive behaviour was able to reduce
transcriptional activity, suggesting that DNA methylation of CpG
sites within this region silences SLC6A4 promoter activity. Using
Alibaba 2.1 program, a list of potential transcription factors that
may interact with the CpG sites was generated. Unquestionably,
future studies are needed to examine the promoter more in depth
to determine whether SLC6A4 expression is regulated by specific
CpG sites and whether there are transcription factor interactions
at specific regions of the promoter. Nevertheless, these findings,
together with the present observed associations between SLC6A4
methylation and 5-HT synthesis and childhood-aggression, may
suggest that methylation is silencing SLC6A4 expression in certain
cells in the periphery and perhaps also the CNS sometimes during
development, as a result of early stress, thereby disrupting the
developmental regulation/ontogeny of the 5-HT system.
This pilot study has some limitations. First, the participants were
limited to healthy males. It would be of interest to see to what
extent the results can be generalized to females. Secondly,
although the sample is comparable with other PET studies, the
sample was too small to reliably investigate interactions between
aggression, 5-HT synthesis and DNA methylation. Third, the
methylation analysis was only done on peripheral tissue and the
state of DNA methylation in the brain was not available. Although
it is not possible to obtain human brain tissue from living
individuals, this type of analysis can be replicated in nonhuman
primates. Fourth, the blood and PET data from the participants
were collected during adulthood and the data obtained was then
associated with the assessments of their childhood aggressive
behaviour. It will be important to obtain brain functioning and
DNA methylation states during childhood, adolescence and
adulthood to fully monitor the development and progression of
DNA methylation of SLC6A4 and brain 5-HT synthesis with the
development of physical aggression. The peripheral DNA
methylation biomarker discovered in our study makes this
repeated measure feasible. Lastly, we are aware that changes in
SLC6A4 promoter methylation and brain 5-HT function may be
due to factors other than aggression. However, in order to
minimize confounders the participants in this study were carefully
selected based on their childhood phenotype and were carefully
screened for presence of any detectable current mental or physical
health problems.
Taken together, this study is among the first to associate
peripheral methylation of the SLC6A4 gene in the blood and in vivo
Figure 3. Methylation regulates gene expression at SLC6A4
promoter. (A) Schematic representation of the 648 bp SLC6A4
promoter construct subcloned into the pCpGL-basic plasmid. CpG sites
are indicated as vertical lines on the gene promoter, the significantly
altered CpG sites in both T cells and monocytes from pyrosequencing
were included in the construct. The TSS, exon 1 and the CpG island
locations within the SLC6A4 promoter are also shown in the figure. (B)
Normalized luciferase activity (RLU/mg protein) in the JAR cell line for
the antisense, sense, and methylated sense promoter constructs are
shown. Values are expressed as mean6SEM. **p,0.01.
doi:10.1371/journal.pone.0039501.g003
SLC6A4 DNA Methylation and Aggression
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supports the relevance of DNA methylation states in peripheral
cells for brain function. The combination of higher SLC6A4
methylation and lower 5-HT synthesis in the brain suggests
vulnerability for impulsive behaviour in subjects with high
childhood-limited aggression. More importantly, the observed
differential SLC6A4 methylation detected in peripheral blood cells
suggests the feasibility of using methylation at specific CpG sites of
SLC6A4 as non-invasive biomarkers of 5-HT synthesis and
behaviours associated with altered 5-HT function such as
aggression. If these results can be confirmed in a larger sample,
methylation of SLC6A4 CpG sites could be used to screen for 5-
HT related psychiatric disorders as well as for the assessment of
preventive and corrective interventions.
Materials and Methods
Participants
Ethical approval was granted by the research committee at
Sainte-Justine Hospital Research Center and written informed
consents were obtained from all participants. Healthy adult males
(mean age6SD: 27.160.7) were selected from a 21 year
longitudinal study with low socioeconomic status French-speaking
families in a disadvantaged area of Montreal (N=1,037) [25].
The participants were followed since kindergarten with evalua-
tions of physical aggression made by teachers at age 6 and
annually between ages 10–15 with the Teacher Form of a
French-Canadian version of the Social Behaviour Questionnaire
[25]. Based on the measurements collected from childhood until
age 15, four different trajectories for physical aggression were
previously identified for the entire sample of the longitudinal
study (N=1,037 [25]). One trajectory showed no physical
aggression at any time points (never); a second trajectory
demonstrated low to moderate aggression and declined between
age 10–15 (low level desister); a third trajectory demonstrated
high rates of aggression, which subsequently declined over time
(childhood-limited high physical aggression (C-LHPA)); a final
trajectory consisted of individuals with consistently high physical
aggression until age 15 (chronic). Chronic aggressive subjects
were not included in our study for the following reasons. First,
our current study compared DNA methylation with imaging data
that was derived from our previous brain 5-HT synthesis imaging
study. That specific study compared healthy individuals who
were aggressive in childhood but desisted in adolescence to the
low level aggression group (See Booij et al. for more details [5]).
Second, the chronic aggressive group is a small minority in the
population that only represents approximately 3% of the entire
cohort [25]. In this particular study, we wanted to focus on the
majority of the population, which belongs to the other three
trajectories. Finally, in the sample we tested, we aimed to limit
the number of confounding factors that could have influenced
the outcome measures, such as drug use, current psychopathol-
ogy etc. Including chronic individuals in the PET study sample
would have been confounded by the heterogeneous nature of the
chronic aggressive group as they are very likely to differ also on
several critical confounders. In this study the participants from
C-LHPA (n=8) were compared with the low physical aggression
(LPA) trajectories consisted of never and low level desister groups
(n=17) [5]. Twenty of the subjects were previously involved in a
study investigating childhood physical aggression and brain 5-HT
synthesis where their [
11C]AMT PET data have been collected
[5]. Briefly, the participants were each given an intravenous
injection of 10 mCi (370 MBq) of a-[
11C]AMT after psychiatric
interview [26] and medical evaluation, then underwent a 60 min
dynamic PET scan using an ECAT HR+ (CTI Molecular
Imaging Inc/Siemens). Furthermore, genotyping data of the
SLC6A4 promoter polymorphism (5-HTTLPR) for these partic-
ipants were obtained by polymerase chain reaction (PCR)
method as previously described [27]. Owing to technical
problems, two monocyte samples, one from each group were
dropped for the pyrosequencing analysis. Moreover, for the C-
LHPA group, one monocyte sample was missing data on CpG 5
and one T cell sample was missing data on CpG 1–14.
Lymphocyte Extraction and Sample Preparation
Peripheral blood samples were collected from participants and
stored in EDTA coated tubes at 4uC before extraction. Peripheral
blood mononuclear cells (PBMC) were isolated by density gradient
centrifugation with Ficoll-Paque (GE Healthcare). Briefly, blood
was mixed with PBS (GIBCO, Invitrogen) and transferred into a
tube with Ficoll-Paque. After 30 min of centrifugation at
2000 rpm at 18uC, the PBMC layer was extracted, washed twice
with HBSS (GIBCO, Invitrogen) and resuspended in PBS/FBS
(PBS with 4% FBS). T cell extraction was done by immunomag-
netic separation with Dynabeads CD3 (Dynal, Invitrogen) and
EasySep Magnet (Stemcell Technologies). Dynalbeads were
agitated and washed twice with PBS/FBS with the magnet, and
incubated with the PBMCs on a nutator at 4uC for 45 min. CD3+
T cells were separated from the PBMCs with the magnet and
washed 3 times with PBS/FBS. CD19+ B cells were also isolated
with Dynabeads CD19 Pan B (Dynal, Invitrogen) and the left over
cells consisted of monocytes. For the purpose of this study, T cells
and monocytes were used for the methylation analysis. After
isolation, the cell pellets were stored at 280uC until further
processing. DNA and RNA extraction were performed using
Trizol (Invitrogen) according to the manufacturer’s instructions
and stored at 220uC and 280uC respectively. RNA qualities were
analyzed using Agilent 2100 Bioanalyzer done by Genome
Quebec.
Pyrosequencing
To investigate the DNA methylation pattern in the target region
214–625 bp upstream of the SLC6A4 gene promoter, three sets of
outside primers and four sets of nested primers were used as
follows: Out F1&2 59-TGTAGTTGGTTAATAAAATGA-
GAATTAGTT-39, Out R1&2 59-AAATCCTAACTTTCC-
TACTCTTTAACTTTA-39, Out F3 59-TTTTAGGAAGAAA-
GAGAG-AGTAGTTTT-39, Out R3 59-
CCAAAAAACTCTTAAAAAATTTTTAC-39, Out F4 59-
TTTGT-TTTTTTGTGTAGTTTTTTTT-39, Out R4 59-
CTCACATAATCTAATCTCTAAATAACC-39, Nest F1 59-
TTTTTTATTGTGGAAGTTTTTATTGTG-39, Nest R1 59-
CTCTCTCTTTCTTCCT-AAAACCTAACA-39, Nest F2 59-
TTGTTAGGTTTTAGGAAGAAAGAGAGA-39, Nest R2 59-
AAAAAAAACTACACAAAAAAACAAATATAC-39, Nest F3
59-TTTTAGGAAGAAAGAG-AGAGTAGTTTT-39, Nest R3
59-AAATCCTAACTTTCCTACTCTTTAACTTTA-39, Nest
F4 59-TAAAGTTAAAGAGTAGGAAAGTTAGGATTT-39,
and Nest R4 59-ACCCCAAAACCA-AAAAAAAA-39. The nested
reverse primers were biotinylated for pyrosequencing. DNA was
treated with sodium bisulfite and two rounds of PCR amplification
was performed as previously described [8]. 15 ml of the PCR
products were used to perform pyrosequencing using Pyro-
MarkQ24 (Qiagen) according to the manufacturer’s protocol.
The methylation percentage at each CpG site was analyzed using
the PyroMark Q24 software (Qiagen).
SLC6A4 DNA Methylation and Aggression
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To generate a 648 bp construct from the SLC6A4 promoter,
outside primers were adapt from a previous study [28], and nested
primers were designed as follows: Sense Fow 59-TTGGATCCT-
GCTAGGTCCCAGGAAGAAA-39, Sense Rev 59-
TTAAGCTTGGGGAAGAAGGTCTGGAA-AG-39, Antisense
Fow 59-TTAAGCTTTGCTAGGTCCCAGGAAGAAA-39, and
Antisense Rev 59-TTGGATCCGGGGAAGAAGGTCTG-
GAAAG-39. Human genomic DNA was subjected to two rounds
of amplification with Failsafe PCR Enzyme Mix (Epicentre) with
the outside and nested sense and antisense primers, digested with
HindIII and BamHI and subcloned into the CpG-free pCpGL-
basic luciferase reporter plasmid. To create methylated constructs,
SssI DNA methyltransferase (New England Biolabs) was used for in
vitro methylation [29]. Using this strategy, CpGs in the promoter
are exclusively methylated with no confounding effect of
methylation of the surrounding plasmid sequence. Both the
methylated and non-methylated plasmids were then transfected
into JAR human placental choriocarcinoma cells (ATCC HTB-
144) that constitutively expresses SLC6A4 [30,31] using standard
calcium phosphate transfection method as previously described
[32]. JAR cells were cultured in RPMI 1640 (GIBCO, Invitrogen)
containing 10% fetal bovine serum (GIBCO, Invitrogen), plated at
a density of 7610
5 cells/well in six-well plates and co-transfected
with 200 ng of plasmid DNA. Cells were harvested and lysed 48 h
after transfection and luciferase activity was measured using the
Luciferase Assay System (Promega).
VOI Analyses
The imaging data were pre-processed, generated and normal-
ized as described previously [5]. Next, VOI were identified as
follows: hippocampus, lateral and medial OBFC, and caudate.
These VOIs were selected based on their prominent role in
emotion regulation and involvement with aggression phenotypes.
Primary VOI for the purpose of this study was the lateral OBFC,
based on our results of our previous study [5]. Associations
between DNA methylation and the other regions were analyzed
for exploratory purposes.
In silico Transcription Factor Binding Analysis
Prediction of potential transcription factor binding sites from
2240 to 2590 of the SLC6A4 promoter was performed using
Alibaba 2.1 program (http://www.gene-regulation.com/pub/
programs/alibaba2/index.html) with the following parameters:
pairism to known sites 50, matrix width 10 bp, minimum number
of sites 4, minimum matrix conservation 80%, similarity of
sequence to matrix 1%, and factor class level 4.
Statistical Analysis
Univariate and multivariate GLM were used to explore
associations between trajectories of aggression and methylation.
For all of these GLM, participants were statistically weighted
according to the posterior probability of belonging to the assigned
trajectory [5,25]. These analyses were not corrected for multiple
comparisons since these analyses were exploratory and primarily
aimed to select specific CpG sites for the more detailed
investigation of our primary research question about the
association between peripheral DNA methylation and in vivo
measures of brain 5-HT synthesis. Pearson’s correlations were
used to assess associations between DNA methylation and brain
measures. The false discovery rate (FDR) was used to adjust for
multiple testing in these latter correlational analyses, using an
adjusted q value of 0.05 [33]. Data were log10 transformed when
required in order to meet the normality assumption for GLM,
however original values are presented throughout the paper to
facilitate interpretation of the data. For some of the CpGs there
was some heterogeneity of variances but given the sample size we
continued using parametric tests. Outliers and influential data
points were investigated by examination of the absolute values of
standardized residuals (.3) and Cooks distance (cutoff .1). No
outliers or influential data points were detected in average levels in
methylation across the 24 CpG sites in T cells or monocytes,
neither in methylation levels in the specifically investigated CpG
sites that were of further investigation (T cells: CpG 11 and 12,
monocytes: CpG 5 and 6). Student’s t-test was used to compare
gene transcriptional activation of the luciferase reporter construct.
The significant threshold is set at p,0.05 and is indicated by
asterisks.
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